- Home
- FHTX vs GPRK Comparison
FHTX vs GPRK Comparison
Compare FHTX & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- GPRK
- Stock Information
- Founded
- FHTX 2015
- GPRK 2002
- Country
- FHTX United States
- GPRK Colombia
- Employees
- FHTX N/A
- GPRK N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- GPRK Oil & Gas Production
- Sector
- FHTX Health Care
- GPRK Energy
- Exchange
- FHTX Nasdaq
- GPRK Nasdaq
- Market Cap
- FHTX 513.7M
- GPRK 432.3M
- IPO Year
- FHTX 2020
- GPRK N/A
- Fundamental
- Price
- FHTX $9.04
- GPRK $7.93
- Analyst Decision
- FHTX Strong Buy
- GPRK Strong Buy
- Analyst Count
- FHTX 5
- GPRK 2
- Target Price
- FHTX $16.00
- GPRK $12.50
- AVG Volume (30 Days)
- FHTX 123.1K
- GPRK 270.9K
- Earning Date
- FHTX 11-04-2024
- GPRK 11-06-2024
- Dividend Yield
- FHTX N/A
- GPRK 7.30%
- EPS Growth
- FHTX N/A
- GPRK N/A
- EPS
- FHTX N/A
- GPRK 1.97
- Revenue
- FHTX $25,515,000.00
- GPRK $716,838,000.00
- Revenue This Year
- FHTX N/A
- GPRK N/A
- Revenue Next Year
- FHTX $15.40
- GPRK $6.45
- P/E Ratio
- FHTX N/A
- GPRK $4.22
- Revenue Growth
- FHTX N/A
- GPRK N/A
- 52 Week Low
- FHTX $2.70
- GPRK $7.24
- 52 Week High
- FHTX $10.25
- GPRK $11.25
- Technical
- Relative Strength Index (RSI)
- FHTX 60.32
- GPRK 45.89
- Support Level
- FHTX $7.95
- GPRK $7.85
- Resistance Level
- FHTX $9.54
- GPRK $8.36
- Average True Range (ATR)
- FHTX 0.52
- GPRK 0.28
- MACD
- FHTX 0.18
- GPRK 0.01
- Stochastic Oscillator
- FHTX 79.17
- GPRK 36.03
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil and Argentina. The company generates revenue from the sale of crude oil, condensate and natural gas net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.